Clinical Trials Browser

Phase 4 × Terminated × Epoetin Alfa × Clear all

NCT00495378 2016-12-20

RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia

Phase 4 Terminated

Classical hematology

Anemia, Neoplasms